Anti-tumor activity of naive and activated class I-restricted tumor-specific TCR-transgenic T cells.

被引：0
|
作者：
Dalyot-Herman, N [1 ]
Malek, TR [1 ]
机构：
[1] Univ Miami, Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
来源：
FASEB JOURNAL | 1999年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A613 / A613
页数：1
相关论文
共 50 条
  • [1] MHC class I-restricted tumor epitope specific TCR engineered CD4+ T cells function as helper and cytolytic effector cells in anti-tumor immunity
    Chhabra, Arvind
    Yang, Lili
    Wang, Pin
    Chakraborty, Nitya G.
    Das, Raja
    Ribas, Antoni
    Kohn, Donald
    Baltimore, David
    Economou, James
    Mukherji, Bijay
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 899 - 899
  • [2] MHC Class I-Restricted TCR-Transgenic CD4+T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In Vivo
    Schober, Sebastian J.
    Thiede, Melanie
    Gassmann, Hendrik
    Prexler, Carolin
    Xue, Busheng
    Schirmer, David
    Wohlleber, Dirk
    Stein, Stefanie
    Grunewald, Thomas G. P.
    Busch, Dirk H.
    Richter, Guenther H. S.
    Burdach, Stefan E. G.
    Thiel, Uwe
    CELLS, 2020, 9 (07) : 1 - 15
  • [3] Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain
    Robert M. Prins
    Chengyi J. Shu
    Caius G. Radu
    Dan D. Vo
    Haumith Khan-Farooqi
    Horacio Soto
    Meng-Yin Yang
    Muh-Shi Lin
    Stephanie Shelly
    Owen N. Witte
    Antoni Ribas
    Linda M. Liau
    Cancer Immunology, Immunotherapy, 2008, 57 : 1279 - 1289
  • [4] Anti-tumor activity and trafficking of self, tumor-specific T cells against tumors located in the brain
    Prins, Robert M.
    Shu, Chengyi J.
    Radu, Caius G.
    Vo, Dan D.
    Khan-Farooqi, Haumith
    Soto, Horacio
    Yang, Meng-Yin
    Lin, Muh-Shi
    Shelly, Stephanie
    Witte, Owen N.
    Ribas, Antoni
    Liau, Linda M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (09) : 1279 - 1289
  • [5] HLA class I-restricted and tumor-specific cytotoxic T lymphocytes from metastatic lymph nodes of esophageal cancers
    Toh, U
    Yamana, H
    Nakao, M
    Imai, Y
    Seki, N
    Takasu, H
    Kaneshige, T
    Fujita, H
    Shirouzu, K
    Itoh, K
    CELLULAR IMMUNOLOGY, 1997, 177 (02) : 137 - 143
  • [6] Functional analysis of TCR-transduced MHC class I-restricted helper T cells and their role in tumor protection
    Morris, EC
    Tsallios, A
    Bendle, G
    Xue, S
    Stauss, HJ
    IMMUNOLOGY, 2005, 116 : 32 - 32
  • [7] Endothelial antigen presentation: Stimulation of previously activated but not naive TCR-transgenic mouse T cells
    Perez, VL
    Henault, L
    Lichtman, AH
    CELLULAR IMMUNOLOGY, 1998, 189 (01) : 31 - 40
  • [8] In vivo trafficking of naive and activated anti-tumor transgenic CD8+ T-cells
    Matsui, K
    Allen, PM
    FASEB JOURNAL, 2001, 15 (04): : A661 - A661
  • [9] MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR
    Soto, Carolina M.
    Stone, Jennifer D.
    Chervin, Adam S.
    Engels, Boris
    Schreiber, Hans
    Roy, Edward J.
    Kranz, David M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (02) : 359 - 369
  • [10] MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR
    Carolina M. Soto
    Jennifer D. Stone
    Adam S. Chervin
    Boris Engels
    Hans Schreiber
    Edward J. Roy
    David M. Kranz
    Cancer Immunology, Immunotherapy, 2013, 62 : 359 - 369
12345